CAS: 22414-26-2; 2-Phenylpropanoyl Chloride

该化合物是一种多用途丙基氯化衍生物,主要用作有机合成的中间体;其反应式碳基氯化物组可产生高效的循环反应,使其对生产药品,农用化学品和精细化学品具有价值;该化合物在受控制条件下表现出很高的纯度和稳定性,确保了在诸如酯化和恐吓等反应中的一致性能;其苯基替代物在允许选择性功能化的同时,增强了电子生物过程的再活动;妥善处理由于其湿度敏感和腐蚀性性质而必不可少;对于实验室和工业应用来说,2-苯基丙基氯化物是精密合成复杂有机分子的可靠试剂.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

hydratropic acid (RS)-2-phenyl-1-propanol fraeseol 2-Phenylpropanal 2-phenyl-propionic acid 2,2'-piperazine-1,4-diyl-diethyl ester (E)-1-chloro-3-phenylbutan-2-one rac-1-(4-methylphenyl)-2-phenylpropan-1-one 3-phenyl-butan-2-one

合成工艺路线路线简述

    杨梅醛置于氯化亚砜,Permanganate(Vii) Ion体系中,化学反应生成2-苯基丙酰氯
    参考文献:酮亚胺的快速酸催化和非催化水合
    标题:酮亚胺的快速酸催化和非催化水合
    摘要:在ph范围为2-13的水中(μ1.0; 25°)中,已经检查了一系列酮亚胺(9)的水合速率.注意到了三种水合成酰胺的机理(8):(a)在2-7的ph范围内,从h 3 O +进行质子转移,产生一般的酸催化作用(给出k H 3 O + / K D 3 O + 2.65);(b)在ph> 7(其中k H 2 O + / K D 2 O += 4.8)下由h 2 O进行的一般酸催化作用;(c)确定ho-攻击的速率.最后一种机制仅显示为n-芳基酮亚胺,例如(9E);其他n-烷基酮亚胺继续通过速率决定质子从水的反应进行反应,即使在ph 13时也是如此.当(9A)在酸性或碱性d 2 O中反应时,仅掺入一个氘,而氘代的酮亚胺(9F )仅掺入一个氘就证实了这一结果.)不会在水中反应时使标签松动.对于涉及从h 3 O +或h 2转移h +的反应,取代基的作用是平行的o; 在改变碳(质子化位点)上的取代基方面
    Doi:10.1039/p29800000579

    海关参考信息

    专利信息


    专利号:US-3959322-A
    优先权日:1960-09-22
    标 题:Synthesis of 13-alkyl-gon-4-ones
    发明人:HUGHES GORDON ALAN; SMITH HERCHEL
    权利人:SMITH HERCHEL
    摘要:The preparation of 13-methylgon-4-enes and novel 13-polycarbonalkylgon-4-enes by a new total synthesis is described. 13-Alkylgon-4-enes having progestational, anabolic and androgenic activities are prepared by forming a tetracylic gonane structure unsaturated in the 1,3,5(10),9(11) and 14-positions, selectively reducing in the B- and C-rings, and converting the aromatic A-ring compounds so-produced to gon-4-enes by Birch reduction and hydrolysis.

    专利号:US-2005009924-A1
    优先权日:2003-07-08
    标 题 :Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives
    发明人:HUANG HSU-SHAN
    摘要:This invention relates to novel anthraquinone compounds useful in the treatment of allergic, inflammatory conditions, antioxidant, tumor condition, stem cell application, tissue engineering, applied in treating age-associate tissue degeneration, reverse organ failure in chronic high-turnover disease and therapeutic compositions containing such compounds. The compounds of the present invention are 1,4-, 1,5- and 1,8-difunctionalized anthraquinones or analogs thereof. According to the practice of the invention, there are provided bis-symmetrical substituted anthraquinone compounds according to formula I: n n nwherein R1, R2, R3 and R4 present a straight, aminoalkylamino side chains or branched chain alkyl group having 1 to 6 carbons which may be substituted with one or more groups of R5, or R1, R2, R3 and R4 present phenyl or benzyl which may be substituted with one or two groups of R6; wherein R5 is selected from the group consisting of halogen, —RNH 2 , —RNH 2 R, —ROH, —NO 2 , —OCH 3 , —OCH 2 CH 3 , and —OCH 2 CH 2 CH 3 ; and wherein R6 is selected from the group consisting of a straight or branched chain alkyl group having 1 to 4 carbons, halogen, —RNH 2 , —RNH 2 R, —ROH, —NO 2 , —OCH 3 , —OCH 2 CH 3 , —OCH 2 CH 2 CH 3 , —CH 2 Br, —CH 2 Cl, —CH 2 OH, —C(CH 3 ) 3 , —(CH 2 ) 2 0H, —(CH 2 ) 3 OH, —(CH 2 ) 4 OH, —CH 2 NH 2 , —(CH 2 ) 2 NH 2 , —(CH 2 ) 3 NH 2 , —(CH 2 ) 4 NH 2 , —(CH 2 ) 5 NH 2 , —CH 2 N(CH 3 ) 2 , —(CH 2 ) 2 N(CH 3 ) 2 , —(CH 2 ) 2 NH(CH 2 ) 2 OH, —(CH 2 ) 3 NH(CH 2 ) 2 OH, —(CH 2 ) 2 NHCH 2 OH, —(CH 2 ) 3 NHCH 2 OH, —CH 2 CH(CH 3 ) 2 , —CHCl 2 , —CH(CH 3 )Cl, —(CH 2 ) 2 Cl, —(CH 2 ) 3 Cl, —(CH 2 ) 3 Br, —(CH 2 ) 4 Br, and —(CH 2 ) 4 Cl. n n Chart 1. Activation of hTERT promoter-driven SEAP expression by c-Myc. About 1×10 7 hTERT-BJ1 cells were transfected with 13.5 μg each of plasmid pSEAP or pPhTERT-SEAP and of plasmid pMT2T or pMT2T-cMyc by electroporation. After 24 h, viable cells were harvested, and reinoculated at a density of 3×10 5 /mL, and the SEAP activity after 24 h at 37 â–¡. The transfection efficiency of each experiment was determined by cotransfection with 1.5 μg of plasmid pCMVβ. The values were determined from three experiments. P<0.05 is presented by an asterisk.

    专利号:WO-9118890-A1
    优先权日:1990-06-07
    标 题:Bicyclic chiral compounds
    发明人:BANKS MALCOLM ROBERT; CADOGAN JOHN IVAN GEORGE; DAWSON IAN MICHAEL; GOSNEY IAN; HODGSON PHILIP KENNETH GORDON
    权利人:BRITISH PETROLEUM CO PLC
    摘要:A compound of general formula I(a) and/or I(b) and/or I(c), in which R1 represents a methyl group or a group of the general formula -CH¿2?.SO2.R?2¿ or -CH¿2?.SO2.NR?2R3¿, in which each of R?2 and R3¿ independently represents an alkyl, cycloalkyl or optionally substituted phenyl or phenalkyl group; each of R?4, R5 and R6¿ independently represents a hydrogen atom or a methyl group; X represents a group of formula C(CH¿3?)2 or, when both of R?5 and R6¿ represent methyl groups, also represents a group of formula CH¿2?; Q represents an oxygen or sulphur atom; and Y represents a hydrogen atom, an alkali metal atom or a group of the general formula -COA in which A represents a halogen atom or an alkyl or alkoxy group optionally substituted by a phenyl, cycloalkyl, alkoxy or alkylcarbonyl group. The compounds are bicyclic optically active compounds and are useful in the synthesis of optical isomers and separation of optical isomers from mixtures.

    专利号:US-4086423-A
    优先权日:1973-10-12
    标题 :Process for cephem synthesis
    发明人:FIRESTONE RAYMOND A; RATCLIFFE RONALD W; CHRISTENSEN BURTON G
    权利人:MERCK & CO INC
    摘要:Cephalosporin antibiotics of the formula: ##STR1## are produced by cycloaddition of a glycine derivative of the formula ##STR2## with a thiazine derivative of the formula ##STR3##

    专利号:EP-0824512-B1
    优先权日:1995-05-12
    标 题 :Synthesis of optically active aminoindanol

    专利号:EP-0824512-A1
    优先权日:1995-05-12
    标题 :Synthesis of optically active aminoindanol
    济南大宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    电话:0531-87153728👤
    📞 济南大宇化工有限公司⚠️参考联系方式

    电话: 0531-87153728
    邮件:xufeng192@jinandayuchem.com
    网址: http://www.jinandayuchem.com
    地址:济南市济阳区济北生命科技园
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    济南市济阳区济北生命科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    济南大宇化工有限公司控股公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司控股公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com
    通信地址: 济南市济阳区济北生命科技园
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市济阳区济北生命科技园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Pcl3-Mediated Transesterification And Aminolysis Of Tert-Butyl Esters Via Acid Chloride Formation
    作者:Xiaofang Wu,Lei Zhou,Fangshao Li,Jing Xiao |发布日期:2021.5
    摘要:A Pcl3-Mediated Conversion Of Tert-Butyl Esters Into Esters And Amides In One-Pot Under Air Is Developed. This Novel Protocol Is Highlighted By The Synthesis Of Skeletons Of Bioactive Molecules And Gram-Scale Reactions. Mechanistic Studies Revealed That This Transformation Involves The Formation Of An Acid Chloride In Situ, Which Is Followed By Reactions With Alcohols Or Amines To Afford The Desired

    合成参考文献


    摘要:Shaabani, A.; Sarvary, A.; Shaabani, S., Science of Synthesis: Multicomponent Reactions, (2013) 2, 103.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知